Raddeanoside R7 inhibits proliferation and migration of ovarian cancer cells through P13K-AKT signaling

Key Points

• Inhibition of proliferation and migration was observed in ovarian cancer cells treated with raddeanoside R7.
• The treatment with raddeanoside R7 resulted in significant reduction of cell growth by approximately 40%.
• Analysis involved evaluating the effects of raddeanoside R7 on PI3K-AKT signaling in ovarian cancer models.
• These findings highlight the therapeutic potential of targeting PI3K-AKT signaling in ovarian cancer treatment.